FDA clears EUA change for Applied DNA coronavirus test
August 3, 2020 -- Applied DNA Sciences announced that the U.S. Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) amendment for its Linea COVID-19 assay kit, a change that it says could boost throughput in labs.
August 3, 2020 -- Applied DNA Sciences announced that the U.S. Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) amendment for its Linea COVID-19 assay kit, a change that it says could boost throughput in labs.
NIH invests almost $249M in 7 COVID-19 test technologies
July 31, 2020 -- The U.S. National Institutes of Health (NIH) is touting the results of its "Shark Tank" approach to spurring development in COVID-19 testing technologies, with $248.7 million invested in a variety of different methods that promise rapid results.
July 31, 2020 -- The U.S. National Institutes of Health (NIH) is touting the results of its "Shark Tank" approach to spurring development in COVID-19 testing technologies, with $248.7 million invested in a variety of different methods that promise rapid results.
PanCan, GeneCentric partner on precision medicine for pancreatic cancer
July 31, 2020 -- The Pancreatic Cancer Action Network (PanCan) and GeneCentric Therapeutics have partnered to conduct research on RNA-based molecular technologies to predict pancreatic cancer disease progression and drug response.
July 31, 2020 -- The Pancreatic Cancer Action Network (PanCan) and GeneCentric Therapeutics have partnered to conduct research on RNA-based molecular technologies to predict pancreatic cancer disease progression and drug response.
Medicare to pay for Myriad's BRCA testing in prostate cancer patients
July 31, 2020 -- Medicare will be covering use of Myriad's BracAnalysis companion diagnostic in men with prostate cancer who may be eligible for treatment with the poly (ADP-ribose) polymerase inhibitor olaparib (Lynparza).
July 31, 2020 -- Medicare will be covering use of Myriad's BracAnalysis companion diagnostic in men with prostate cancer who may be eligible for treatment with the poly (ADP-ribose) polymerase inhibitor olaparib (Lynparza).
Tau blood test shows promise for very early Alzheimer's detection
July 29, 2020 -- An elevated level of the protein tau phosphorylated at threonine 217 is an accurate biomarker for the early detection of Alzheimer's disease and appears to be specific to the pathology, according to studies reported July 28 at the annual Alzheimer's Association International Conference.
Discuss
July 29, 2020 -- An elevated level of the protein tau phosphorylated at threonine 217 is an accurate biomarker for the early detection of Alzheimer's disease and appears to be specific to the pathology, according to studies reported July 28 at the annual Alzheimer's Association International Conference.
Discuss Humana to mail 1M home screening kits amid COVID-19
July 24, 2020 -- Health insurer Humana has announced it will mail more than 1 million in-home preventive care screening kits to members amid the ongoing novel coronavirus pandemic.
July 24, 2020 -- Health insurer Humana has announced it will mail more than 1 million in-home preventive care screening kits to members amid the ongoing novel coronavirus pandemic.
Urine test could assess cystic fibrosis' effects on the kidneys
July 24, 2020 -- A urine test could be used to determine the effects of cystic fibrosis in the kidneys, according to a July 23 study in the Journal of the American Society of Nephrology.
July 24, 2020 -- A urine test could be used to determine the effects of cystic fibrosis in the kidneys, according to a July 23 study in the Journal of the American Society of Nephrology.
CRP test guides steroid Rx for coronavirus, could help save lives
July 22, 2020 -- The level of C-reactive protein (CRP) in the blood of coronavirus patients could help safely guide treatment with steroids, which have the potential to save many thousands of lives, researchers reported July 22 online in the Journal of Hospital Medicine.
Discuss
July 22, 2020 -- The level of C-reactive protein (CRP) in the blood of coronavirus patients could help safely guide treatment with steroids, which have the potential to save many thousands of lives, researchers reported July 22 online in the Journal of Hospital Medicine.
Discuss Mailing FIT kits to Medicaid patients could boost colon cancer screening rates
July 21, 2020 -- Mailing fecal immunochemical test (FIT) kits to U.S. Medicaid patients could increase the rate of colon cancer screening and appears to be cost-effective, according to a modeling study published online July 20 in the journal Cancer.
Discuss
July 21, 2020 -- Mailing fecal immunochemical test (FIT) kits to U.S. Medicaid patients could increase the rate of colon cancer screening and appears to be cost-effective, according to a modeling study published online July 20 in the journal Cancer.
Discuss COVID-19 more severe in even mildly obese patients
July 16, 2020 -- People with any degree of obesity are at greater risk of more severe COVID-19 symptoms and death, according to a study published July 16 in the European Journal of Endocrinology. Based on the results, researchers called for a better understanding of patients' metabolic profiles.
July 16, 2020 -- People with any degree of obesity are at greater risk of more severe COVID-19 symptoms and death, according to a study published July 16 in the European Journal of Endocrinology. Based on the results, researchers called for a better understanding of patients' metabolic profiles.